Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31476276 | 0.88 | MEN1 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL28461004 | 0.83 | LMNA (0.38) | LMNAHSD17B10 | |
| SCHEMBL31264402 | 0.80 | MEN1 (0.34) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL10445031 | 0.75 | CYP4F2 (0.44) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL2937013 | 0.75 | — | — | |
| SCHEMBL29444579 | 0.73 | NAAA (0.46) | ALDH1A1TP53CYP3A4MAPK1LMNA | |
| SCHEMBL31482753 | 0.71 | ALDH1A1 (0.34) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL10785861 | 0.70 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL6061671 | 0.70 | MEN1 (0.37) | CYP4F2CYP4A11 | |
| SCHEMBL30950138 | 0.69 | ALDH1A1 (0.38) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12370130-B1 | Preparation method for powder product, powder product, and powder commodity | A & H INTERNATIONAL COSMETICS CO., LTD (CN) | 2025-07-29 | — | — | US | claimed |
| CN-116421558-B | Skin external agent composition containing crosslinked hyaluronic acid gel | 株式会社爱茉莉太平洋 | 2025-06-03 | — | — | CN | claimed |
| CN-119792148-A | Transparent emulsion with high oil content and preparation method thereof | 福建片仔癀化妆品股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-4534067-A1 | PREPARATION METHOD FOR POWDER PRODUCT, POWDER PRODUCT, AND POWDER COMMODITY | A & H International Cosmetics Co., Ltd (CN) | 2025-04-09 | — | — | EP | claimed |
| CN-119630381-A | Liquid oily composition and cosmetic containing the same | 日清奥利友集团株式会社 | 2025-03-14 | — | — | CN | claimed |
| CN-119096106-A | Method for removing water from functional ingredient compositions and compositions containing the resulting products | 凯姆令克实验室有限责任公司 | 2024-12-06 | — | — | CN | claimed |
| US-20240390238-A1 | MINIMALIST EMULSION COMPOSITIONS | ICB (an ABC), LLC | 2024-11-28 | — | — | US | claimed |
| CN-118319784-A | Semitransparent cosmetic composition | 株式会社爱茉莉太平洋 | 2024-07-12 | — | — | CN | claimed |
| WO-2024142969-A1 | WATER-IN-OIL EMULSION COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | claimed |
| CN-117942282-A | Cosmetic composition | JNTL消费者健康株式会社 | 2024-04-30 | — | — | CN | claimed |
| WO-2022006038-A1 | COSMETIC COMPOSITION HAVING STABILIZED RETINOL | L'OREAL (FR) | 2022-01-06 | — | — | WO | claimed |
| US-20210401696-A1 | COSMETIC COMPOSITION HAVING STABILIZED RETINOL | L'OREAL (FR) | 2021-12-30 | — | — | US | claimed |
| CN-107735074-B | Surfactant-free dispersion liquid containing solid lipid microparticles and cosmetic composition using same | 株式会社爱茉莉太平洋 | 2021-07-20 | — | — | CN | claimed |
| CN-106535874-B | Pore reducing agent | 玫琳凯有限公司 | 2021-05-04 | — | — | CN | claimed |
| CN-106999369-B | Lip solid cosmetic | 株式会社资生堂 | 2021-04-13 | — | — | CN | claimed |
| CN-112451394-A | Mild makeup remover | 广东柏俐臣生物科技有限公司 | 2021-03-09 | — | — | CN | claimed |
| CN-112153963-A | Liquid crystal emulsified composition for facial mask, preparation method of liquid crystal emulsified composition and facial mask comprising liquid crystal emulsified composition | 丽得姿化妆品株式会社 | 2020-12-29 | — | — | CN | claimed |
| CN-112120942-A | Cosmetic composition of non-surfactant type | 株式会社爱茉莉太平洋 | 2020-12-25 | — | — | CN | claimed |
| CN-111386099-A | Emulsified cosmetic | 株式会社资生堂 | 2020-07-07 | — | — | CN | claimed |
| US-20200048484-A1 | ALCOHOL-BASED DRY-ERASABLE INK | SOCIéTé BIC (FR) | 2020-02-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401696-A1 | COSMETIC COMPOSITION HAVING STABILIZED RETINOL | RARA, RBP4, RARG | ALDH1A1 69/4885TP53 547/4885CYP3A4 3579/4885 |
| US-20240390238-A1 | MINIMALIST EMULSION COMPOSITIONS | ADH7, PROC, OTC | ALDH1A1 225/4885TP53 1219/4885CYP3A4 4713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.